Last edition
News about "warm autoimmune hemolytic anemia (wAIHA)"
US FDA Approves IMAAVY as First Treatment for Warm Autoimmune Hemolytic Anemia
The US Food and Drug Administration (FDA) has approved IMAAVY (nipocalimab-aahu) as the first treatment for warm autoimmune hemolytic anemia, based on durable hemoglobin responses in phase 2/3.
Warm Autoimmune Hemolytic Anemia (wAIHA) | 26/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members